DARS™ Stock Ratings for AZN

If you were a Dividend.com Premium member, you would be seeing detailed DARS™ Dividend Stock Ratings information for AstraZeneca (AZN) in this space. Sign up for Dividend.com Premium today to gain access to ratings on nearly 2,000 dividend-paying stocks, exclusive members-only articles, historical dividend information, and more!

Subscribe to Dividend.com Premium Today! »

Recent Dividend.com Articles for AZN

• Best Large Cap Dividend Stock Prospects List - Mar.6 Edition
  Sat, Mar 6, 2010
• Best Large Cap Dividend Stock Prospects List - Feb.27 Edition
  Sat, Feb 27, 2010
• Best Large Cap Dividend Stock Prospects List - Feb.20 Edition
  Sat, Feb 20, 2010
• Best Large Cap Dividend Stock Prospects List - Feb.13 Edition
  Sat, Feb 13, 2010
• Dividend Stock Leaders and Laggards from the Week of Feb.1-5 (PNC, ARG, MA, EMR, HOT, NEM, more)
  Sat, Feb 6, 2010
• Best Large Cap Dividend Stock Prospects List - Feb.6 Edition
  Sat, Feb 6, 2010
• Best Large Cap Dividend Stock Prospects List - Jan.30 Edition
  Sat, Jan 30, 2010
• Best Large Cap Dividend Stock Prospects List - Jan.23 Edition
  Sat, Jan 23, 2010
• Best Large Cap Dividend Stock Prospects List - Jan.16 Edition
  Sat, Jan 16, 2010
• Dividend Highlights and Lowlights for May.11
  Mon, May 11, 2009
• Dividend Highlights and Lowlights for Mar. 30
  Mon, Mar 30, 2009
• Heart Study Boosting AstraZeneca Prospects (AZN)
  Mon, Nov 10, 2008
• 20 Dividend Stocks Removed from Our Recommended List
  Tue, Oct 7, 2008
• Foreign Pharmaceutical Dividend Winners (AZN, GSK)
  Sun, Jul 6, 2008

Company Profile & Recommendation

Company Profile

AstraZeneca- (AZN)-the company is one of the world's leading pharmaceutical companies, with a broad range of medicines designed to fight disease in important areas of healthcare. Its broad product portfolio includes many world leaders and a number of key products: Arimidex (cancer), Crestor (cardiovascular), Nexium (gastrointestinal disease), Seroquel (schizophrenia and bipolar disorder) and Symbicort (asthma and chronic obstructive pulmonary disease). With their recent acquisition of MedImmune, they have added a world-class biologics and vaccines capability. They have over 67,000 employees (55% in Europe, 30% in the Americas and 15% Asia, Africa and Australasia). AstraZeneca was founded in 1992. It was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in 1999. The company is headquartered in London, the United Kingdom.

* Stock price reflects previous day's closing price. All stock quotes on this website should be considered as having a 24-hour delay.

** Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. The author is not registered as an investment adviser. The author may or may not hold positions in the securities mentioned in this article or video. The author relies upon the "publisher's exclusion" from the definition of "investment adviser" as provided under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws.

*** All dividend payout and date information on this website is for information purposes only. We do not guarantee the accuracy of any dividend dates or payout amounts. Always check with your broker first before purchasing any security.